Related Experiment Video
Updated: Sep 20, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Use of modified ultrafiltration after repair of congenital heart defects
1Department of Pediatric Cardiothoracic Surgery, The Children's Hospital of Philadelphia, Philadelphia, PA.
Insights
Modified ultrafiltration (MUF) reduces fluid overload and inflammatory mediators after pediatric cardiopulmonary bypass (CPB). This technique improves hemodynamics, decreases blood transfusions, and lowers complication rates in children undergoing heart surgery.
Area of Science:
- Pediatric Cardiac Surgery
- Cardiopulmonary Bypass (CPB)
- Fluid Management
Background:
- CPB in children with congenital heart defects causes hemodilution and hypothermia.
- Blood exposure to CPB circuits triggers systemic inflammation, leading to edema and organ dysfunction.
- Existing methods to manage CPB-induced fluid overload include ultrafiltration, dialysis, hemofiltration, and diuretics.
Purpose of the Study:
- To evaluate the efficacy of modified ultrafiltration (MUF) in managing fluid overload and inflammation post-CPB.
- To assess MUF's impact on hemodynamics, blood transfusion needs, and patient outcomes.
- To determine if MUF reduces specific complications like pleural effusions.
Main Methods:
- MUF performed in the immediate post-CPB period to remove excess water and salvage blood.
- Prospective randomized trial comparing MUF with non-filtered controls.
- Measurement of inflammatory mediators (IL-6, IL-8, TNF) and hemodynamic parameters.
Main Results:
- MUF effectively removed excess water, reducing total body water (TBW).
- MUF modulated the inflammatory response by clearing mediators like IL-6, IL-8, and TNF.
- Patients receiving MUF showed improved hemodynamics, reduced need for blood transfusions, and better left ventricular systolic function.
Conclusions:
- MUF is a valuable adjunct to CPB in pediatric cardiac surgery.
- MUF significantly decreases perioperative morbidity, including pleural effusions after major procedures.
- MUF improves patient outcomes by mitigating CPB-induced complications.
Abstract:
The use of cardiopulmonary bypass (CPB) for repair of congenital heart defects exposes children to extremes of hemodilution and hypothermia. Exposure of blood to the foreign surfaces of the oxygenator and bypass circuit initiates a systemic inflammatory response. Adverse effects of CPB include increased capillary permeability and increased total body water (TBW), which often results in tissue edema and multiple organ dysfunction. A variety of techniques have been developed for reversing tissue edema and hemodilution after CPB, including ultrafiltration during CPB, postoperative peritoneal dialysis, postoperative continuous arterial venous hemofiltration, and aggressive use of diuretics. A technique termed modified ultrafiltration (MUF) has been developed at the Hospital for Sick Children in London. Unlike conventional ultrafiltration, MUF is performed in the immediate post-CPB period and removes excess water from the patient as well as provides a method of salvaging blood from the circuit. MUF has been shown to modulate the inflammatory response to CPB by removing inflammatory mediators including interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF). A prospective randomized trial of MUF showed improved hemodynamics with a reduction in TBW and decreased need for blood transfusion when compared with nonfiltered controls. MUF has been shown to improve left ventricular systolic function after CPB, resulting in increased systolic blood pressure and cardiac index. In a recent study, use of MUF significantly reduced the incidence of pleural effusions after cavopulmonary connection and the Fontan procedure. MUF is a useful adjunct to CPB in children and significantly decreases perioperative morbidity. Copyright 1998 by W.B. Saunders Company
More Related Videos
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Hemodialysis I: Introduction

